Inverse benefit law
From Infogalactic: the planetary knowledge core
Lua error in package.lua at line 80: module 'strict' not found.
The inverse benefit law states that the more a new drug is marketed, the worse it is for patients. More precisely, the ratio of benefits to harms among patients taking new drugs tends to vary inversely with how extensively a drug is marketed. Two Americans, Howard Brody and Donald Light, have defined the inverse benefit law, inspired by Tudor Hart's inverse care law.[1]
See also
- Disease mongering
- Health policy
- Inverse care law
- Medicalization
- Patient safety
- Pharmaceutical marketing
- Public health
- Quaternary prevention
